key: cord-0781838-ggpbkqfm authors: Almaghrabi, Reem S.; Alsagheir, Osamah I.; Alquaiz, Rawan M.; Alhekail, Othman Z.; Abaalkhail, Abdulrahman M.; Alduaij, Atheer A.; Algwaiz, Ghadah F.; Alkaff, Morad A.; Althawadi, Sahar I. title: Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a tertiary care hospital in Riyadh, Saudi Arabia date: 2021-11-29 journal: IJID Regions DOI: 10.1016/j.ijregi.2021.11.009 sha: b0f79b3b2e696b16c80dd5330d2b7f38e223d012 doc_id: 781838 cord_uid: ggpbkqfm Background The SARS-CoV-2 pandemic has led to a strain on medical resources. The development of countermeasures to prevent its spread is evolving. Health care workers (HCWs) are at high risk for contracting and transmitting the disease. Methods We performed serology testing of volunteer HCWs at King Faisal Specialist Hospital and Research Center in Riyadh (The Center) in order to determine the prevalence of SARS-CoV-2 antibodies as well as determining the associated risk factors in hopes of implementing adequate prevention and control measures. Results 1,076 subjects participated in this study, in which 24.3% were seropositive. The majority were nurses (379, 35%) or physicians (245, 22.2%). 392 of the 1,076 (36.4%) subjects were caregivers for COVID-19 patients and 463 (43.0%) reported contact with infected employees. There was a statistically significant association between taking care of COVID-19 patients and being diagnosed with COVID-19 (Chi square test, P-value = 0.046). There was a significant association between being in contact with infected employees and having positive IgG (Chi Square test, P-value <0.001). Conclusions A baseline analysis of SARS-CoV-2 seropositivity in HCWs at a large tertiary care hospital in Riyadh was performed as the first part of a prospective study of HCWs. The reported seropositivity was 24.3%, higher than that of other hospitals in Riyadh. IgG testing was very useful in the detection of previous SARS-CoV-2 infection as it has high negative predictive value. The novel coronavirus (SARS-CoV-2) which causes COVID-19 disease was first detected in Wuhan, China in December 2019. Since its discovery, the number of cases rose rapidly, rendering it the next international health concern. On the 11th of March 2020, the World Health Organization officially declared COVID-19 disease a global pandemic. At the time of writing this manuscript, the rapid spread of the infection has resulted in a total of 127 million cases and 2.8 million deaths worldwide. (Dong et al., 2020) About 388,000 cases have been detected in Saudi Arabia as of March 2021. (Dong et al., 2020) Health care workers (HCWs) are considered to be at high risk for contracting and transmitting COVID-19 disease. The hospital acquired COVID-19 rate for both inpatients and HCWs has been reported to be as high as 44%. (Barranco et al., 2021) HCWs can also play a role in transmitting infection due to lack of knowledge about the disease, especially early during the pandemic when proper personal protective measures were not well defined. (Karlsson et al., 2020) At King Faisal Specialist Hospital and Research Center in Riyadh, the majority of the patients are immunocompromised, placing them at higher risk for severe infection. In this study, we performed serology testing of HCWs at our Center in order to determine the prevalence of SARS-CoV-2 antibodies and to determine associated risk factors in hopes of implementing improved prevention and control measures. This is a single center observational prospective cohort study conducted at King Faisal Specialist Hospital and Research Center in Riyadh (The Center), Saudi Arabia from June, 2020 to December, 2021. Serum SARS-COV-2 antibody prevalence will be determined at 3 different time points at baseline, 6 and 12 months later. This study represents the first set of antibodies, the baseline, which was collected over 6 months, from June to December, 2020. During this phase, none of the participants have received COVID-19 vaccine as it was not yet available in Saudi Arabia. Nasopharyngeal and throat swabs were used for COVID-19 PCR and the PCR results were used to make a diagnosis of COVID-19 infection. An email was sent to all Center employees stating the aim and objectives of the study and asking them to participate. All study subjects completed an online survey consisting of a set of variables that included subject demographics, whether they were assigned to patients infected with SARS-CoV-2, whether they used personal protective equipment (PPE) as directed by the hospital infection control and hospital epidemiology department, if they had contact with infected employees and the dates and duration of the contact, if they were diagnosed with COVID-19 disease, and any related symptoms. The duration of contact with infected employees was divided into 2 groups, contact less than 15 minutes, and contact more than 15 minutes. Serum testing for the SARS-COV-2 antibody was performed after completing the survey. The Center research ethical committee granted a waiver of informed consent for this study. Participants were divided according to their occupation into clinical and nonclinical jobs for further risk stratification. Clinical jobs included physicians, nurses, lab technicians, radiology technicians, respiratory therapists, pharmacists and paramedics. Nonclinical jobs were social services, housing services, dietary and nutrition services, IT support, and administrative jobs. Work areas for nurses were classified into high and low-risk areas. High-risk areas were COVID-19 units, the emergency department, and intensive care units. Low-risk areas were non-COVID-19 general wards, operating rooms, labor and delivery units, and the outpatient department. Participating employees were divided into three groups; Group 1 took care of COVID-19 patients, Group 2 had contact with a COVID positive employee, and Group 3 did not take care of COVID-19 patients and had no contact with infected employees. RNA extraction was performed using Bioneer's ExiProgen™ RT-PCR kit and Kingfisher semi - Qualitative detection of serum antibodies to SARS-CoV-2 was performed using the Elecsys® Anti-SARS-CoV-2 kit (Roche Diagnostics) and reported as a positive or negative serology. This assay uses a recombinant protein representing the nucleocapsid antigen in a double-antigen sandwich assay format, which favors detection of high affinity antibodies against SARS-CoV-2. A SARS-CoV-2 IgG assay was performed using the ARCHITECT i System (Abbott Diagnostics) to detect immunoglobulin class G (IgG) antibodies to the nucleocapsid protein of SARS-CoV-6 2 in serum from patients. Results of this testing were used for the sensitivity and specificity analysis. Subject demographics and risk factors were summarized using the mean, median, percentage, interquartile range and standard deviation. A chi-square test was used to evaluate correlations between risk factors and COVID-19 disease. Univariate and multivariable logistic regression analyses were used to evaluate the odds of seroconverting between different groups. Sensitivity and specificity were calculated for IgG antibodies as a diagnostic tool for infection in HCWs. Statistical analyses were performed using IBM SPSS V.26. P values of <0.05 were considered statistically significant. 1,076 subjects participated in this study. There were 647 (60.1%) women. The mean subject age was 38.4 ± 11.6 years ( Table 1) . 925 (85.9%) subjects were non-smokers (Table 1 ). Most subjects (775, 72%) had clinical jobs and were involved in direct patient care. The majority were nurses (379, 35%) or physicians (245, 22.8%). Of the nurses, 222 (58.58%) worked in low-risk areas and 157 (41.42%) worked in high-risk areas. 392 of the 1,076 (36.4%) subjects were caregivers for COVID-19 patients (Group 1), 463 (43%) reported contact with infected employees (Group2), and 221 (20.5%) did not work with COVID-19 patient nor had contact with an infected employee (Group 3). The majority of subjects were symptomatic at the time of diagnosis. Headache, fever, upper respiratory tract symptoms and diarrhea were the most common presenting symptoms. Forty-one subjects (15.5%) reported no symptoms at time of diagnosis. There was a statistically significant association between taking care of COVID-19 patients and being diagnosed with COVID-19 disease (Chi square test, P-value = 0.046). There was no significant association between taking care of COVID-19 patients and being symptomatic at diagnosis (Chi square test, P-value = 0.079). Ninety-three subjects (20.1%) who had contact with infected employees were diagnosed with COVID-19 disease and 75 (80.6 %) of these individuals were symptomatic at the time of diagnosis. There was a significant association between being in contact with infected employees and being symptomatic at the time of diagnosis (Chi square test, P-value=0.002). Among the employees in group 3, 115 (52%) were diagnosed with COVID-19 disease, of whom 64 (55.6%) were symptomatic at diagnosis. The three employee risk groups were evaluated. 743 (69.0%) of the subjects reported wearing proper PPE. PPE use was reported more frequently in Group 1 than in Group 2 (93.4% vs. 81.4%, respectively) ( Table 2 ). Most subjects in Group 2 reported a contact duration of more than 15 minutes with infected employees (298, 64.4%). There was no association between the duration of contact with infected employees and diagnosis with COVID-19 disease (Chi square test, P-value= 0.224). Out of 1076 participants, the overall seropositivity rate was 24.3% (Table 1) . Seventy-one (18%) of the HCWs assigned to COVID-19 patients (Group 1) were found to have positive IgG antibody results from their sera. There was no significant association between taking care of COVID-19 patients and having positive IgG antibodies (Chi Square test, p-value=0.215). Of the subjects that had contact with infected employees, 68 (14.7%) were seropositive for IgG antibody. There was a significant association between being in contact with infected employees and having positive IgG (Chi Square test, P-value <0.001). (Table 3 ). A nationwide study in Saudi Arabia reported a SARS-CoV-2 seropositivity rate of 2.3% among HCWs in different hospitals and regions in Saudi Arabia in May, 2020, in the early stages of the pandemic. (Alseregi et al., 2021) The highest rates of seropositivity were identified in Makkah region (6.31%) and Al-Madinah region (4.55%), hotspots of SARS-CoV-2 infection, early in the pandemic in Saudi Arabia. (Alserehi et al., 2021) A seropositivity rate of 24.4% in HCWs was reported in Al-Madinah region from April to June, 2020. (Alharbi et al., 2020) In contrast, a seropositivity rate of 2.36%, 6.3%, and 7.5% in healthy blood donors, non-COVID-19 patients and HCWs, respectively, was reported from Riyadh region from June to August, 2020. (Alharbi et al., 2021) A national study evaluating the finding of SARS-CoV-2 antibodies in healthy blood donors, non-COVID-19 patients and HCWs reported a national seropositivity rate of 11% (range: 1.78-24.45%). (Alharbi et al., 2021) We now report the baseline results of a planned prospective study evaluating the prevalence and durability of SARS-CoV-2 antibody response in workers at a tertiary care hospital in Riyadh, Saudi Arabia from June to December, 2020. The overall prevalence rate of this cohort was 24.3%. These findings demonstrate an increase in seropositivity in our HCWs with progression of the pandemic. A potential cause of part of this increase is the improper use of PPEs. About 20% of Group 2, subjects that did not deliver care to COVID-19 patients, but were in contact with SARS-CoV-2 infected hospital staff, did not use masks when they were in contact with the infected staff. Universal masking for all hospital employees was implemented early October 2020, four months after the start of this study. Including time to become proficient with this new policy and also including the incubation period of SARS-CoV-2 infection, subjects were relatively unprotected for the majority of the study period. Implementation of PPEs in developed, high income countries has been shown to decrease the rate of conversion to SARS-CoV-2 seropositivity from 21.3%, a rate similar to ours, to 11.46%, a mean decline of 0.49% per day. (Wang et al., 2020) Testing of HCWs was performed at a New York City hospital from May to June, 2020, during an intense period of the pandemic in that city that was associated with PPE use by physicians. There was a higher rate of seropositivity among office staff (25.8%) and administrative HCWs (20.9%), compared to physicians (18.1%). (Purswan iet al., 2021) These finding suggest the proper use PPEs in a health care setting contribute to control of disease spread. (Purswani et al., 2021) Physicians in this study had differences in SARS-CoV-2 antibody seropositivity according to the zip code of the residence, possibly due to differences in disease prevalence in the city and altered use of PPEs when away from the hospital. (Purswani et al., 2021) Published reports of the rate of asymptomatic COVID-19 patients vary. The SARS-CoV-2 seropositive rate of HCWs at major hospitals undergoing voluntary screening ranged from zero to 7.5% in March and April of 2020. (Al-Zoubi et al., 2020; Treibel et al., 2020) About a year into this study, 15.4% of PCR positive subjects we examined were asymptomatic at the time of diagnosis. These subjects were likely tested as part of the hospital routine screening protocol or as part of contact tracing. This higher rate of asymptomatic COVID-19 disease in HCWs is likely related to a higher rate of community transmission occurring at this late date and with the introduction of routine PCR testing. (Borges et al., 2021) Genomic and epidemiological analysis revealed the outbreak was caused by HCW-Patient and HCW-HCW transmission. (Borges et al., 2021) Identification of the pattern of spread led to the introduction or emphasis of several safety measures including frequent hand cleansing, maintenance of a safe physical distance, and mandatory use of respiratory protection. These findings have particular relevance with the emergence of different SARS-CoV-2 variants thought to be more transmissible and possible associated with higher mortality. (Davies et al., 2021; Challen et al., 2020) There were several limitations to this study. Recruitment was slow; it took 6 months to accrue 1,076 subjects. During the study period, IgM antibodies were not tested for all employees due to shortage of kits during the pandemic, however IgG kits were available throughout the study period. This study presents the findings in volunteers, which may not be representative of the population working at The Center as a whole. No data regarding community exposure was available. These factors could affect the high rate of seropositivity seen in this study. Subject medical data which could affect the rate of seropositivity or development of symptoms was not available. IgG testing revealed SARS-CoV-2 serological testing was highly sensitive, specific, and had a high negative predictive value in the diagnosis of COVID-19 disease. These findings may not help with disease containment as IgG is expected to appear later in the course of the disease. In contrast, PCR testing yields an early positive result. (Murad et al., 2021) Early diagnosis can lead to the early introduction of isolation and quarantine practices. In areas with limited COVID-19 vaccine availability, these findings may be used to prioritize vaccination to seronegative HCWs. Patient risk assessment may be performed using IgG testing as the presence of anti-spike or anti-nucleocapsid SARS-CoV-2 IgG antibodies has been reported to be associated with a substantially reduced risk of reinfection for at least 6 months. (Lumley et al., 2021) Conclusions A baseline analysis of SARS-CoV-2 seropositivity in HCWs at a large tertiary care hospital in Riyadh was performed as the first part of a prospective study of HCWs. The reported seropositivity was 24.3%, higher than that of other hospitals in Riyadh. IgG testing was very useful in the detection of previous SARS-CoV-2 infection as it has high negative predictive value. Saudi Arabia Saudi Arabia Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers among healthcare workers in Saudi Arabia: comparing case and control hospitals Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study Hospital-Acquired SARS-Cov-2 Infections in Patients: Inevitable Conditions or Medical Malpractice? Nosocomial Outbreak of SARS-CoV-2 in a Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01. medRxiv. 2021. time Covid-19: risks to healthcare workers and their families Infection in Health Care Workers SARS-Cov2 Infection Detection by Polymerase Chain Reaction and Serologic Testing in Clinical Practice SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital COVID-19: PCR screening of asymptomatic healthcare workers at London hospital Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers 03%) Job at KFSH&RC Clinical duties, n (%) Non-clinical duties, n (%) 775 (72.03%) 301 (27.97%) Nurses' area of coverage High risk, n (%) Low risk, n (%) † There was an overlap between the groups in 27 subjects who've took care of COVID-19 patients and were in contact with infected employees Table 3. Sensitivity and specificity using IgG for the diagnosis of COVID-19 The present study is supported by a grant fund for medical trainees of the department of medicine.Ethical considerations were in compliance with the hospital's office of research affairs. All data has been deidentified and collected in a password-secured Redcap form accessible only to investigators.No potential conflict of interest relevant to this article was reported.